140 related articles for article (PubMed ID: 7972934)
1. Transforming growth factor-alpha and epidermal growth factor inhibit gastric acid secretion and stimulate release of somatostatin and neurotensin in the conscious rat.
Grupcev G; Wallin C; Emås S; Theodorsson E; Hellström PM
Regul Pept; 1994 Jul; 52(2):111-8. PubMed ID: 7972934
[TBL] [Abstract][Full Text] [Related]
2. Release of regulatory gut peptides somatostatin, neurotensin and vasoactive intestinal peptide by acid and hyperosmolal solutions in the intestine in conscious rats.
Rudholm T; Wallin B; Theodorsson E; Näslund E; Hellström PM
Regul Pept; 2009 Jan; 152(1-3):8-12. PubMed ID: 18992283
[TBL] [Abstract][Full Text] [Related]
3. Release of somatostatin, neurotensin and vasoactive intestinal peptide upon inhibition of gastric acid secretion by duodenal acid and hyperosmolal solutions in the conscious rat.
Wallin C; Grupcev G; Emås S; Theodorsson E; Hellström PM
Acta Physiol Scand; 1995 Jun; 154(2):193-203. PubMed ID: 7572215
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory actions of insulin-like growth factor-I and transforming growth factor-alpha on intestinal neurotensin and peptide YY.
Lee HM; Udupi V; Englander EW; Rajaraman S; Coffey RJ; Greeley GH
Endocrinology; 1999 Sep; 140(9):4065-9. PubMed ID: 10465277
[TBL] [Abstract][Full Text] [Related]
5. Pertussis toxin-sensitive inhibition of glucagon-like peptide 1-stimulated acid production by epidermal growth factor and transforming growth factor alpha in rat parietal cells.
Schmidtler J; Dehne K; Schusdziarra V; Classen M; Schepp W
Eur J Pharmacol; 1993 Jun; 246(1):59-66. PubMed ID: 8394819
[TBL] [Abstract][Full Text] [Related]
6. Effects of various gastrointestinal peptides on parietal cells and endocrine cells in the oxyntic mucosa of rat stomach.
El Munshid HA; Håkanson R; Liedberg G; Sundler F
J Physiol; 1980 Aug; 305():249-65. PubMed ID: 6108365
[TBL] [Abstract][Full Text] [Related]
7. Anesthetic dependence of the inhibitory effect of neurotensin on pentagastrin-stimulated acid secretion in rats. A possible role for somatostatin.
Hammer RA; Fernandez C; Ertan A; Arimura A
Life Sci; 1991; 48(4):333-9. PubMed ID: 1671292
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of acid secretory response and induction of ornithine decarboxylase and its mRNA by TGF alpha and EGF in isolated rat gastric glands.
Wojciechowski K; Trzeciak L; Konturek SJ; Ostrowski J
Regul Pept; 1995 Mar; 56(1):1-8. PubMed ID: 7770629
[TBL] [Abstract][Full Text] [Related]
9. Mucosal expression and luminal release of epidermal and transforming growth factors in patients with duodenal ulcer before and after eradication of Helicobacter pylori.
Konturek PC; Ernst H; Konturek SJ; Bobrzyński AJ; Faller G; Klingler C; Hahn EG
Gut; 1997 Apr; 40(4):463-9. PubMed ID: 9176072
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the antisecretory and antiulcer activity of epidermal growth factor, urogastrone and transforming growth factor alpha and its derivative in rodents in vivo.
Bastaki SM; Chandranath SI; Singh J
Mol Cell Biochem; 2002 Jul; 236(1-2):83-94. PubMed ID: 12190125
[TBL] [Abstract][Full Text] [Related]
11. Comparison between transforming growth factor alpha and epidermal growth factor in the protection of rat gastric mucosa against drug-induced injury.
Romano M; Kraus ER; Boland CR; Coffey RJ
Ital J Gastroenterol; 1994 Jun; 26(5):223-8. PubMed ID: 7522648
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin as a mediator of the effect of neurotensin on pentagastrin-stimulated acid secretion in rats.
Hammer RA; Ochoa A; Fernandez C; Ertan A; Arimura A
Peptides; 1992; 13(6):1175-9. PubMed ID: 1362980
[TBL] [Abstract][Full Text] [Related]
13. Effect of epidermal growth factor, transforming growth factor alpha and nerve growth factor on gastric mucosal integrity and microcirculation in the rat.
Tepperman BL; Soper BD
Regul Pept; 1994 Feb; 50(1):13-21. PubMed ID: 8159804
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor and transforming growth factor-alpha directly inhibit parietal cell function through a similar mechanism.
Wang L; Lucey MR; Fras AM; Wilson EJ; Del Valle J
J Pharmacol Exp Ther; 1993 Apr; 265(1):308-13. PubMed ID: 8474014
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin and oxyntomodulin-(30-37) potentiate PYY regulation of gastric acid and somatostatin secretions.
Bado A; Cloarec D; Moizo L; Laigneau JP; Bataille D; Lewin MJ
Am J Physiol; 1993 Jul; 265(1 Pt 1):G113-7. PubMed ID: 8101697
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of inhibitory action of secretin on gastric acid secretion in conscious rats.
Shimizu K; Li P; Lee KY; Chang TM; Chey WY
J Physiol; 1995 Oct; 488 ( Pt 2)(Pt 2):501-8. PubMed ID: 8568688
[TBL] [Abstract][Full Text] [Related]
17. Gastric secretion and gastrin under progressive doses of somatostatin-14 and -28 administered intraperitoneally to the rat.
Seefried G; Schmidtler J; Schwille PO
Peptides; 1988; 9(2):249-55. PubMed ID: 2897678
[TBL] [Abstract][Full Text] [Related]
18. Effect of transforming growth factor-alpha on gastric acid secretion in rats and monkeys.
Guglietta A; Lesch CA; Romano M; McClure RW; Coffey RJ
Dig Dis Sci; 1994 Jan; 39(1):177-82. PubMed ID: 8281854
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of parietal cell acid secretion is mediated by the classical epidermal growth factor receptor.
Joshi V; Ray GS; Goldenring JR
Dig Dis Sci; 1997 Jun; 42(6):1194-8. PubMed ID: 9201084
[TBL] [Abstract][Full Text] [Related]
20. Expression of epidermal growth factor and transforming growth factor alpha during ulcer healing. Time sequence study.
Konturek PC; Brzozowski T; Konturek SJ; Ernst H; Drozdowicz D; Pajdo R; Hahn EG
Scand J Gastroenterol; 1997 Jan; 32(1):6-15. PubMed ID: 9018760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
